Cargando…

Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke

BACKGROUND: The related factors affecting the adherence of ischemic cerebral stroke (ICS) patients to antiplatelet therapy have attracted much attention. METHODS: Patients with ICS (confirmed by CT or MRI) were enrolled from January 2020 to July 2021. The demographic data were retrospectively invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Jie, Gao, Yuguang, Huang, Deqing, Hu, Yueqiang, He, Qianchao, Diao, Limei, Hu, Yuying, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175999/
https://www.ncbi.nlm.nih.gov/pubmed/37062920
http://dx.doi.org/10.1002/brb3.2982
_version_ 1785040339913932800
author Zhong, Jie
Gao, Yuguang
Huang, Deqing
Hu, Yueqiang
He, Qianchao
Diao, Limei
Hu, Yuying
Chen, Wei
author_facet Zhong, Jie
Gao, Yuguang
Huang, Deqing
Hu, Yueqiang
He, Qianchao
Diao, Limei
Hu, Yuying
Chen, Wei
author_sort Zhong, Jie
collection PubMed
description BACKGROUND: The related factors affecting the adherence of ischemic cerebral stroke (ICS) patients to antiplatelet therapy have attracted much attention. METHODS: Patients with ICS (confirmed by CT or MRI) were enrolled from January 2020 to July 2021. The demographic data were retrospectively investigated and analyzed. The adherence calculation was as follows: Adherence = number of tablets taken/number of tablets needed to be taken. Adherence < 100% was defined as nonadherence. Severe nonadherence is defined as adherence ≤ 75%. RESULTS: A total of 229 patients with ICS were enrolled. We found no significant difference in the proportion of patients with nonadherence, while the proportion of severe nonadherence in the aspirin group was significantly higher (p < .001). Multivariable analysis indicated that medical insurance (odds ratio [OR] = 0.071, p < .001) and regular exercise (OR = 0.438, p = .015) were independent factors associated with adherence. In addition, only medical insurance (OR = 5.475, p < .001) and aspirin treatment (OR = 0.228, p < .001) were independent risk factors associated with severe nonadherence. We therefore constructed a nomogram plot and a model as follows: Adherence risk score = 3 × medical insurance + regular exercise. Patients were divided into low‐risk and high‐risk groups for adherence based on the median model score. A total of 13.3% of patients in the low‐risk group were nonadherent patients compared with 53.4% in the high‐risk group (p < .001). Similarly, 8.4% of patients in the low‐risk group had severe nonadherence compared with 19.9% in the high‐risk group (p = .022). Moreover, in low‐risk patients, no significant difference was observed. In patients with high risk, aspirin‐treated patients showed significantly decreased adherence compared with the other two groups. CONCLUSION: Medical insurance and regular exercise were independent factors for antiplatelet therapy adherence. For patients with high model scores, timely intervention is necessary.
format Online
Article
Text
id pubmed-10175999
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101759992023-05-13 Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke Zhong, Jie Gao, Yuguang Huang, Deqing Hu, Yueqiang He, Qianchao Diao, Limei Hu, Yuying Chen, Wei Brain Behav Original Articles BACKGROUND: The related factors affecting the adherence of ischemic cerebral stroke (ICS) patients to antiplatelet therapy have attracted much attention. METHODS: Patients with ICS (confirmed by CT or MRI) were enrolled from January 2020 to July 2021. The demographic data were retrospectively investigated and analyzed. The adherence calculation was as follows: Adherence = number of tablets taken/number of tablets needed to be taken. Adherence < 100% was defined as nonadherence. Severe nonadherence is defined as adherence ≤ 75%. RESULTS: A total of 229 patients with ICS were enrolled. We found no significant difference in the proportion of patients with nonadherence, while the proportion of severe nonadherence in the aspirin group was significantly higher (p < .001). Multivariable analysis indicated that medical insurance (odds ratio [OR] = 0.071, p < .001) and regular exercise (OR = 0.438, p = .015) were independent factors associated with adherence. In addition, only medical insurance (OR = 5.475, p < .001) and aspirin treatment (OR = 0.228, p < .001) were independent risk factors associated with severe nonadherence. We therefore constructed a nomogram plot and a model as follows: Adherence risk score = 3 × medical insurance + regular exercise. Patients were divided into low‐risk and high‐risk groups for adherence based on the median model score. A total of 13.3% of patients in the low‐risk group were nonadherent patients compared with 53.4% in the high‐risk group (p < .001). Similarly, 8.4% of patients in the low‐risk group had severe nonadherence compared with 19.9% in the high‐risk group (p = .022). Moreover, in low‐risk patients, no significant difference was observed. In patients with high risk, aspirin‐treated patients showed significantly decreased adherence compared with the other two groups. CONCLUSION: Medical insurance and regular exercise were independent factors for antiplatelet therapy adherence. For patients with high model scores, timely intervention is necessary. John Wiley and Sons Inc. 2023-04-16 /pmc/articles/PMC10175999/ /pubmed/37062920 http://dx.doi.org/10.1002/brb3.2982 Text en © 2023 The Authors. Brain and Behavior published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Zhong, Jie
Gao, Yuguang
Huang, Deqing
Hu, Yueqiang
He, Qianchao
Diao, Limei
Hu, Yuying
Chen, Wei
Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke
title Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke
title_full Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke
title_fullStr Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke
title_full_unstemmed Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke
title_short Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke
title_sort analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175999/
https://www.ncbi.nlm.nih.gov/pubmed/37062920
http://dx.doi.org/10.1002/brb3.2982
work_keys_str_mv AT zhongjie analysisofantiplatelettherapyadherenceinpatientswithischemiccerebralstroke
AT gaoyuguang analysisofantiplatelettherapyadherenceinpatientswithischemiccerebralstroke
AT huangdeqing analysisofantiplatelettherapyadherenceinpatientswithischemiccerebralstroke
AT huyueqiang analysisofantiplatelettherapyadherenceinpatientswithischemiccerebralstroke
AT heqianchao analysisofantiplatelettherapyadherenceinpatientswithischemiccerebralstroke
AT diaolimei analysisofantiplatelettherapyadherenceinpatientswithischemiccerebralstroke
AT huyuying analysisofantiplatelettherapyadherenceinpatientswithischemiccerebralstroke
AT chenwei analysisofantiplatelettherapyadherenceinpatientswithischemiccerebralstroke